Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Fermagate in Hyperphosphataemia (ALCON)
NCT00358722Phase 2Terminated
- Sponsor
- INEOS Healthcare Limited
- Start
- Jul 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of fermagate in hyperphosphatemia, sponsored by INEOS Healthcare Limited. Started Jul 2006; status: terminated.
02
Drugs
fermagate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00358722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358722.